Analyze Diet
Journal of veterinary pharmacology and therapeutics2012; 36(3); 292-297; doi: 10.1111/jvp.12001

The isolated perfused equine distal limb as an ex vivo model for pharmacokinetic studies.

Abstract: Even though intra-articular injections play an important role in the treatment of joint-related lameness in horses, little is known about pharmacokinetic properties of substances used. Therefore, an ex vivo model for pharmacokinetic studies was developed using distal forelimbs of slaughtered horses. The extremity was perfused with gassed Tyrode solution for up to 8 h. Tissue viability was confirmed by measurements of glucose consumption, lactate production, and lactate dehydrogenase activity in the perfusate. Standard criteria for tissue viability had been determined in preliminary experiments (n = 11), which also included histological examinations of the joint capsule. As the model's first implementation, the articular efflux rate of betamethasone (BM), administered as BM disodium phosphate intra-articularly to the fetlock joint (4 mg BM/joint), was investigated. The concentration of BM in the venous perfusate of the radial vein was measured by means of high-performance liquid chromatography. The average BM efflux rate per minute was calculated to be 5.1 μg/min with values ranging from 9 μg/min to 2.9 μg/min. 7.5 h after i.a. application, 2.3 mg BM had left the joint via the radial vein. Using this inexpensive setup, the presented model allows studying a variety of pharmacological topics without the ethical limitations of animal studies.
Publication Date: 2012-08-23 PubMed ID: 22913456DOI: 10.1111/jvp.12001Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article discusses the development of an ex vivo model using the distal forelimb of a horse for studying the pharmacokinetics of substances used for intra-articular injections, with betamethasone as an early example.

Development of the Ex Vivo Model

  • The study talks about developing an ex vivo model for studying the pharmacokinetic properties of substances used in intra-articular injections to treat joint-related lameness in horses. Intra-articular injections are common forms of treatment but their pharmacokinetic properties, or how the substance moves within the body, are not well understood.
  • For the model, the distal forelimbs of slaughtered horses were isolated. These isolated forelimbs were perfused with a gassed Tyrode solution for up to eight hours. Tyrode’s solution is a solution of eight salts in water and is often used for perfusing mammalian organs.
  • Tissue viability was confirmed using measurements of glucose consumption, lactate production, and lactate dehydrogenase activity in the perfusate, thus demonstrating that the model effectively supports the tissues.

Implementation of the Model and Results

  • The study then presents the first implementation of this model, testing the articular efflux rate of betamethasone. Betamethasone is a glucocorticoid steroid often used for joint disease in horses.
  • The medicine was administered in the form of betamethasone disodium phosphate, and its concentration was measured using high-performance liquid chromatography, a common method for analyzing mixtures of organic compounds.
  • The average betamethasone efflux rate per minute was calculated to be approximately 5.1 μg/min, seven and a half hours after intra-articular application, it was found that about 2.3 mg of betamethasone had left the joint via the radial vein.

Benefits of the Model

  • One significant point in the study is the ethical advantage of this model. Using an ex vivo model means the experiments can be conducted without harming live animals.
  • This model is also inexpensive to set up, enabling versatile study of various pharmacological issues.

Cite This Article

APA
Friebe M, Stahl J, Kietzmann M. (2012). The isolated perfused equine distal limb as an ex vivo model for pharmacokinetic studies. J Vet Pharmacol Ther, 36(3), 292-297. https://doi.org/10.1111/jvp.12001

Publication

ISSN: 1365-2885
NlmUniqueID: 7910920
Country: England
Language: English
Volume: 36
Issue: 3
Pages: 292-297

Researcher Affiliations

Friebe, M
  • Department of Pharmacology, Toxicology and Pharmacy, University of Veterinary Medicine Hannover, Foundation, Hannover, Germany. maren.friebe@tiho-hannover.de
Stahl, J
    Kietzmann, M

      MeSH Terms

      • Administration, Intravenous / veterinary
      • Animals
      • Anti-Inflammatory Agents / administration & dosage
      • Anti-Inflammatory Agents / pharmacokinetics
      • Betamethasone / administration & dosage
      • Betamethasone / pharmacokinetics
      • Cadaver
      • Female
      • Forelimb / blood supply
      • Forelimb / physiology
      • Glucose / metabolism
      • Horses / physiology
      • Lactic Acid / metabolism
      • Male

      Citations

      This article has been cited 2 times.